"Long-acting Injectable Cabotegravir for HIV Pre-exposure Prophylaxis: What we know, What we don’t know, What we need to know for public health impact”
Discussion and Q&A moderated by Dr. Kenneth Mayer, MD
Dr. Mayer is Director of the HU CFAR Bio-Behavioral and Community Science Core,
Medical Research Director and Co-Chair of The Fenway Institute,
Professor of Medicine at Harvard Medical School and Professor, Department of Global Health and Population at Harvard School of Public Health
Presenter:
Raphael J. Landovitz, MD MSc
Professor of Medicine, Division of Infectious Diseases, David Geffen School of Medicine at UCLA